Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population

Abstract Prior knowledge of allele frequencies of cytochrome P450 polymorphisms in a population is crucial for the revision and optimization of existing medication choices and doses. In the current study, the frequency of the CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, CYP2C19*6, CYP2C19*17, and CYP3A...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rattanaporn Sukprasong, Sumonrat Chuwongwattana, Napatrupron Koomdee, Thawinee Jantararoungtong, Santirhat Prommas, Pimonpan Jinda, Jiratha Rachanakul, Nutthan Nuntharadthanaphong, Nutcha Jongjitsook, Apichaya Puangpetch, Chonlaphat Sukasem
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/74bcb67535044068aa1971e2450ebe29
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:74bcb67535044068aa1971e2450ebe29
record_format dspace
spelling oai:doaj.org-article:74bcb67535044068aa1971e2450ebe292021-12-02T17:47:03ZAllele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population10.1038/s41598-021-90969-y2045-2322https://doaj.org/article/74bcb67535044068aa1971e2450ebe292021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90969-yhttps://doaj.org/toc/2045-2322Abstract Prior knowledge of allele frequencies of cytochrome P450 polymorphisms in a population is crucial for the revision and optimization of existing medication choices and doses. In the current study, the frequency of the CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, CYP2C19*6, CYP2C19*17, and CYP3A4 (rs4646437) alleles in a Thai population across different regions of Thailand was examined. Tests for polymorphisms of CYP2C9 and CYP3A4 were performed using TaqMan SNP genotyping assay and CYP2C19 was performed using two different methods; TaqMan SNP genotyping assay and Luminex x Tag V3. The blood samples were collected from 1205 unrelated healthy individuals across different regions within Thailand. Polymorphisms of CYP2C9 and CYP2C19 were transformed into phenotypes, which included normal metabolizer (NM), intermediate metabolizer (IM), poor metabolizer (PM), and rapid metabolizers (RM). The CYP2C9 allele frequencies among the Thai population were 0.08% and 5.27% for the CYP2C9*2 and CYP2C9*3 alleles, respectively. The CYP2C19 allele frequencies among the Thai population were 25.60%, 2.50%, 0.10%, and 1.80% for the CYP2C19*2, CYP2C19*3, CYP2C19*6, and CYP2C19*17 alleles, respectively. The allele frequency of the CYP3A4 (rs4646437) variant allele was 28.50% in the Thai population. The frequency of the CYP2C9*3 allele was significantly lower among the Northern Thai population (P < 0.001). The frequency of the CYP2C19*17 allele was significantly higher in the Southern Thai population (P < 0.001). Our results may provide an understanding of the ethnic differences in drug responses and support for the utilization of pharmacogenomics testing in clinical practice.Rattanaporn SukprasongSumonrat ChuwongwattanaNapatrupron KoomdeeThawinee JantararoungtongSantirhat PrommasPimonpan JindaJiratha RachanakulNutthan NuntharadthanaphongNutcha JongjitsookApichaya PuangpetchChonlaphat SukasemNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rattanaporn Sukprasong
Sumonrat Chuwongwattana
Napatrupron Koomdee
Thawinee Jantararoungtong
Santirhat Prommas
Pimonpan Jinda
Jiratha Rachanakul
Nutthan Nuntharadthanaphong
Nutcha Jongjitsook
Apichaya Puangpetch
Chonlaphat Sukasem
Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
description Abstract Prior knowledge of allele frequencies of cytochrome P450 polymorphisms in a population is crucial for the revision and optimization of existing medication choices and doses. In the current study, the frequency of the CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, CYP2C19*6, CYP2C19*17, and CYP3A4 (rs4646437) alleles in a Thai population across different regions of Thailand was examined. Tests for polymorphisms of CYP2C9 and CYP3A4 were performed using TaqMan SNP genotyping assay and CYP2C19 was performed using two different methods; TaqMan SNP genotyping assay and Luminex x Tag V3. The blood samples were collected from 1205 unrelated healthy individuals across different regions within Thailand. Polymorphisms of CYP2C9 and CYP2C19 were transformed into phenotypes, which included normal metabolizer (NM), intermediate metabolizer (IM), poor metabolizer (PM), and rapid metabolizers (RM). The CYP2C9 allele frequencies among the Thai population were 0.08% and 5.27% for the CYP2C9*2 and CYP2C9*3 alleles, respectively. The CYP2C19 allele frequencies among the Thai population were 25.60%, 2.50%, 0.10%, and 1.80% for the CYP2C19*2, CYP2C19*3, CYP2C19*6, and CYP2C19*17 alleles, respectively. The allele frequency of the CYP3A4 (rs4646437) variant allele was 28.50% in the Thai population. The frequency of the CYP2C9*3 allele was significantly lower among the Northern Thai population (P < 0.001). The frequency of the CYP2C19*17 allele was significantly higher in the Southern Thai population (P < 0.001). Our results may provide an understanding of the ethnic differences in drug responses and support for the utilization of pharmacogenomics testing in clinical practice.
format article
author Rattanaporn Sukprasong
Sumonrat Chuwongwattana
Napatrupron Koomdee
Thawinee Jantararoungtong
Santirhat Prommas
Pimonpan Jinda
Jiratha Rachanakul
Nutthan Nuntharadthanaphong
Nutcha Jongjitsook
Apichaya Puangpetch
Chonlaphat Sukasem
author_facet Rattanaporn Sukprasong
Sumonrat Chuwongwattana
Napatrupron Koomdee
Thawinee Jantararoungtong
Santirhat Prommas
Pimonpan Jinda
Jiratha Rachanakul
Nutthan Nuntharadthanaphong
Nutcha Jongjitsook
Apichaya Puangpetch
Chonlaphat Sukasem
author_sort Rattanaporn Sukprasong
title Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
title_short Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
title_full Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
title_fullStr Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
title_full_unstemmed Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
title_sort allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes cyp2c9, cyp2c19, and cyp3a4 in a thai population
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/74bcb67535044068aa1971e2450ebe29
work_keys_str_mv AT rattanapornsukprasong allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT sumonratchuwongwattana allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT napatrupronkoomdee allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT thawineejantararoungtong allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT santirhatprommas allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT pimonpanjinda allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT jiratharachanakul allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT nutthannuntharadthanaphong allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT nutchajongjitsook allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT apichayapuangpetch allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
AT chonlaphatsukasem allelefrequenciesofsinglenucleotidepolymorphismsofclinicallyimportantdrugmetabolizingenzymescyp2c9cyp2c19andcyp3a4inathaipopulation
_version_ 1718379535846604800